Latest News

Title
Seventh European Advocacy in Action Forum 2016
26 Jan 2017 Nivolumab as Salvage Therapy in Pretreated Patients with Advanced Gastric or Gastro-oesophageal Junction Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy
25 Jan 2017 NICE Issues Recommendations for Pomalidomide in Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib Haematologic malignancies - Anticancer agents & Biologic therapy
23 Jan 2017 Palliative Care Fellowships
23 Jan 2017 Ibrutinib, First FDA-Approved Therapy for Marginal Zone Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
20 Jan 2017 GI Cancer Patient Guides Now in Portuguese: Colorectal, Liver, Oesophageal, Pancreatic and Stomach Cancer
Application
18 Jan 2017 Press Release: Biosimilars Create Opportunities for Sustainable Cancer Care Anticancer agents & Biologic therapy
17 Jan 2017 FDA Approves Bevacizumab Plus Chemotherapy, Followed by Bevacizumab Alone, for the Treatment of Patients with Platinum-Sensitive Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
16 Jan 2017 ESMO supports the 7th EACR-OECI Joint Training Course: Molecular Pathology Approach to Cancer (8 - 10 May 2017, Amsterdam, Netherlands)
16 Jan 2017 FDA Grants Priority Review for Atezolizumab in First-Line Treatment of Patients With Urothelial Carcinoma Who are Not Eligible for Cisplatin Chemotherapy Genitourinary cancers - Cancer Immunology and Immunotherapy
13 Jan 2017 Tailored Scientific Advice to Support Step-by-Step Development of New Biosimilars Bioethics, legal and economic issues
12 Jan 2017 NICE Issues Recommendations for Pembrolizumab in PD-L1-positive Locally Advanced or Metastatic NSCLC After Chemotherapy Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
10 Jan 2017 EU-funded MoTriColor Project for Patients with Metastatic CRC Translational research - Gastrointestinal cancers